GlassScriptPhysician profile
Jonathan Matthew Rayman
NPI 1427475607
$4,600.22
in general payments reported to CMS, 2019-2025
41 companies · $688 in 2025
The $688 reported for 2025 was more than what a typical Foot & Ankle Surgery provider received nationally (typical 2025 total: $424).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $472 · 2020: $263 · 2021: $526 · 2022: $719 · 2023: $862 · 2024: $1,071 · 2025: $688.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $2,312 · Long Term Medical Supply Or Device Loan: $308.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $2,312.41 |
| Long Term Medical Supply Or Device Loan | $307.90 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Smith+Nephew, INC. | $738.74 | 2019-2025 | Bioinductive Implant With Arthroscopic Delivery System - Medium, Bone Anchors With Arthroscopic Delivery System, Collagenase Santyl |
| Kerecis Limited | $464.12 | 2022-2025 | Kerecis Omega3 Marigen, Kerecis Omega3 Surgiclose, Kerecis Omega3 Graftguide |
| Integra Lifesciences Corporation | $385.26 | 2021-2024 | Duragen Dural Graft Matrix, Duragen, Integra |
| Treace Medical Concepts, INC. | $300.34 | 2023-2025 | |
| Melinta Therapeutics, LLC | $228.90 | 2019-2022 | |
| Abbvie INC. | $217.24 | 2022-2025 | |
| Organogenesis INC. | $211.15 | 2020-2023 | Puraply |
| Paratek Pharmaceuticals, INC. | $170.28 | 2019-2025 | Nuzyra |
| Paragon 28, INC. | $168.25 | 2019-2023 | Precision Guide Lapidus |
| Horizon Therapeutics Plc | $162.30 | 2019-2023 | Krystexxa |
| Stryker Corporation | $153.88 | 2019-2025 | Ortholoc 2 Lapifuse, Allofiber, Ortholoc 3di Crosscheck |
| Boston Scientific Corporation | $138.17 | 2024 | |
| Amgen INC. | $118.70 | 2024-2025 | Krystexxa |
| Nevro Corp. | $93.35 | 2021-2023 | Senza |
| Osteomed LLC | $87.45 | 2019 |
Show all 41 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Misonix INC | $87.04 | 2020-2021 | |
| Convatec INC. | $74.86 | 2022-2024 | |
| Abbott Laboratories | $74.19 | 2025 | Proclaim |
| Bioventus LLC | $69.90 | 2021-2025 | Exogen Ultrasound Bone Healing System |
| Urgo Medical North America, LLC | $66.27 | 2024 | Vashe Wound Solution 250 Ml (8.5 Fl Oz) Flip Top Cap, Urgok2 |
| Grt US Holding, INC. | $65.28 | 2022 | |
| Wright Medical Technology, INC. | $64.05 | 2019-2020 | |
| Hartmann USA, INC. | $63.49 | 2020-2023 | Zetuvit Plus |
| Heron Therapeutics, INC. | $50.44 | 2021 | |
| Zak Ortho | $43.96 | 2025 | |
| Mimedx Group, INC. | $32.99 | 2024-2025 | |
| Acera Surgical, INC. | $29.75 | 2025 | Restrata Wound Matrix |
| Medtronic Vascular, INC. | $24.07 | 2019 | |
| Nestle Healthcare Nutrition INC. | $24.01 | 2021 | |
| Orthofix Medical, INC. | $23.86 | 2020-2021 | |
| Medline Industries LP | $20.01 | 2024 | |
| Reprise Biomedical, INC. | $18.89 | 2021 | |
| Kci USA, INC. | $18.32 | 2023 | Kerramax Care, Snap |
| Nabriva Therapeutics, Plc | $18.12 | 2022 | |
| Ovik Health, LLC | $16.81 | 2024 | Coflex Tlc |
| Ermi LLC | $16.73 | 2019 | |
| Arthrex, INC. | $16.31 | 2021 | |
| Penumbra, INC. | $15.95 | 2023 | Indigo System |
| Allergan, INC. | $11.02 | 2019 | |
| Lifenet Health | $9.46 | 2023-2024 | Theragenesis Wound Matrix |
| Cashflow Solutions, LLC | $6.31 | 2024 | Pcd-51 731a (US) - White, Pcd-52 737a (US) White, Lympha Press Optimal Plus(US) Bt |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Jonathan Rayman listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.